Literature DB >> 2851357

Noradrenaline release evoked by a physiological irregular sympathetic discharge pattern is modulated by prejunctional alpha- and beta-adrenoceptors in vivo.

T Kahan1, J Pernow, J Schwieler, B G Wallin, J M Lundberg, P Hjemdahl.   

Abstract

1. Sympathetic nerve stimulation-evoked overflow of endogenous noradrenaline (NA) and vasoconstriction were studied in canine blood-perfused gracilis muscle in situ. Nerves were stimulated at an average frequency of 2 Hz (240 pulses, 120 s) with impulses derived from a recording of the normal irregular sympathetic discharge to human skeletal muscle, with regular bursts of impulses, or with the conventional continuous stimulus mode. 2. Variations in impulse activity were closely paralleled by changes in vascular tone. However, all stimulation patterns evoked the same integrated NA overflow and the same degree of vasoconstriction. 3. Blockade of beta-adrenoceptors by propranolol (0.5 mg kg-1 i.v.) significantly reduced NA overflow and vasoconstriction evoked both by continuous and irregular nerve stimulation, by approximately 15-20%. 4. The enhancement of NA overflow following alpha-adrenoceptor blockade by phenoxybenzamine (0.5 mg kg-1 local i.a.) was significantly greater when evoked by continuous than by irregular nerve discharge (24 vs 14 fold). Effects were similar with irregular and regular burst activity. Half of this enhancement has been shown to be due to blockade of neuronal uptake of NA by phenoxybenzamine. Vasoconstrictor responses to all stimulation patterns were similarly reduced, but not abolished, by phenoxybenzamine. 5. The normal irregular sympathetic discharge seems to evoke a similar integrated NA release and equally pronounced vasoconstriction as stimulation with regular bursts or at constant frequency. We provide additional evidence for a physiological prejunctional alpha-adrenoceptor-mediated inhibition of NA release. This mechanism may be influenced by the discharge pattern. Also prejunctional beta-adrenoceptors seem to modulate NA release under physiological conditions. However, the alpha-adrenoceptor-mediated mechanism is quantitatively more important.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851357      PMCID: PMC1854281          DOI: 10.1111/j.1476-5381.1988.tb11744.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection.

Authors:  P Hjemdahl
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

Review 2.  Presynaptic alpha-autoreceptors.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1987       Impact factor: 5.545

3.  Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.

Authors:  T Kahan
Journal:  Acta Physiol Scand Suppl       Date:  1987

4.  Pre- and postjunctional alpha-adrenoceptor-mediated effects of prazosin, methoxamine and 6-fluoronoradrenaline in blood-perfused canine skeletal muscle in situ.

Authors:  T Kahan; P Hjemdahl
Journal:  Eur J Pharmacol       Date:  1987-01-06       Impact factor: 4.432

5.  Facilitation of nerve stimulation evoked noradrenaline overflow by isoprenaline but not by circulating adrenaline in the dog in vivo.

Authors:  T Kahan; C Dahlöf; P Hjemdahl
Journal:  Life Sci       Date:  1987-05-04       Impact factor: 5.037

6.  A dual function for adenosine 5'-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent.

Authors:  G Burnstock; C Kennedy
Journal:  Circ Res       Date:  1986-03       Impact factor: 17.367

7.  Influence of acetylcholine, peptides, and other vasodilators on endogenous noradrenaline overflow and vasoconstriction in canine blood perfused gracilis muscle.

Authors:  T Kahan; C Dahlöf; P Hjemdahl
Journal:  Acta Physiol Scand       Date:  1985-07

8.  Prejunctional beta 2-adrenoreceptor blockade reduces nerve stimulation evoked release of endogenous noradrenaline in skeletal muscle in situ.

Authors:  C Dahlöf; T Kahan; B Ablad
Journal:  Acta Physiol Scand       Date:  1987-04

9.  Relationship between the overflow of endogenous and radiolabelled noradrenaline from canine blood perfused gracilis muscle.

Authors:  T Kahan; P Hjemdahl; C Dahlöf
Journal:  Acta Physiol Scand       Date:  1984-12

10.  Prejunctional alpha-adrenoceptor-mediated inhibition of norepinephrine release in blood-perfused skeletal muscle in situ.

Authors:  T Kahan; C Dahlöf; P Hjemdahl
Journal:  J Cardiovasc Pharmacol       Date:  1987-05       Impact factor: 3.105

View more
  5 in total

Review 1.  Sympathetic control of reflex cutaneous vasoconstriction in human aging.

Authors:  Jody L Greaney; Lacy M Alexander; W Larry Kenney
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

2.  Influence of the renin-angiotensin system on sympathetic neurotransmission in canine skeletal muscle in vivo.

Authors:  J H Schwieler; T Kahan; J Nussberger; P Hjemdahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

3.  The role of α-adrenergic receptors in mediating beat-by-beat sympathetic vascular transduction in the forearm of resting man.

Authors:  Seth T Fairfax; Seth W Holwerda; Daniel P Credeur; Mozow Y Zuidema; John H Medley; Peter C Dyke; D Walter Wray; Michael J Davis; Paul J Fadel
Journal:  J Physiol       Date:  2013-05-07       Impact factor: 5.182

4.  Single-unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover.

Authors:  Elisabeth A Lambert; Markus P Schlaich; Tye Dawood; Carolina Sari; Reena Chopra; David A Barton; David M Kaye; Mikael Elam; Murray D Esler; Gavin W Lambert
Journal:  J Physiol       Date:  2011-03-14       Impact factor: 5.182

5.  Advances in sympathetic nerve recording in humans.

Authors:  Elisabeth Lambert; Dagmara Hering; Markus Schlaich; Gavin Lambert
Journal:  Front Physiol       Date:  2012-02-07       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.